PARTICIPANTS

Moderator: Ehrin Armstrong, MD

Panelists: Eric A. Secemsky, MD, MSc; Venita Chandra, MD; Parag J. Patel, MD, MS; Raghu Kolluri, MD, MS

Submission & selection process

  • Email abstracts to abstracts@viva-foundation.org as a Word Document or PDF by May 15th
  • Submissions will be reviewed after the deadline. Abstracts will be evaluated and scored based on the following criteria:
    • Interest to field
    • Research methods
    • Quality of data
    • Primary endpoint presented
  • Notification of acceptance or rejection will be sent on Thursday, May 22nd. Subsequent communication will provide further instructions for submitting presentation slides and participating in the webinar.

REQUIREMENTS

  • Research must be original and may not have been presented or published prior to the webinar on June 25th.
  • Abstracts must include the following information, either in the body of the submission email or as a cover page in the abstract document:
    • Title of abstract presentation
    • Name of the company or entity providing funding or research support
    • Presenter information:
      • Name + degree
      • Organization/institution
      • Phone number
      • Email address
  • Abstracts should address areas of endovascular medicine/intervention and can report the results of basic science investigations as well as clinical or pre-clinical studies.
  • Abstracts must include:
    • Trial name
    • Purpose
    • Methods and materials
    • Results
    • Conclusion
  • The total abstract length may not exceed 2,500 characters, excluding the abstract title and any figures/tables.

Please direct questions to Brita Thorne at abstracts@viva-foundation.org.


EMBARGO POLICY

Accepted abstracts are embargoed until the late-breaking webinar on June 25th. No publication or affiliated company may release the information until then.